Tacrolimus BSA Conjugate Solution

• Description:

  Tacrolimus BSA Conjugate Solution

  Catalog #	P2010001
  Size	1.00 mg
  Other Names	BSA-Tacrolimus, Tacrolimus-BSA, BSA conjugated to Tacrolimus, FK506-BSA, BSA-FK506, Tacrolimus Bovine Serum Albumin Conjugate, Tacrolimus [BSA].
  Molecular Weight	71 kDa (average)
  Concentration	Lot-Dependent (2.0-4.0 mg/mL)
  Purity	>95%
  Storage	-20°C. Avoid repeated freeze/thaw cycles.
  Supplied as	Liquid solution
  Buffer	1X Phosphate Buffer Saline, pH 7.4.
  Keywords	BSA conjugate, Tacrolimus 32, Tacrolimus, FK-506, Fujimycin, Prograf, Advagraf, Protopic

    Complete Tacrolimus Product Line Download Brochure References

  • Brunet, M., Plana, J. C., and Rimola, A. (2001). Tacrolimus. Madrid: Drug Farma.
  • Goto, T., and Nakagawa, H. (2004). Development of Tacrolimus Ointment. Tacrolimus Ointment, 81‚Äì98.
  • Raptis, D., and Pramateftakis, M.-G. (2013). Tacrolimus: Effectiveness, safety and drug interactions. New York: Nova Biomedical.
  • Plosker, G. L., and Foster, R. H. (2001). Tacrolimus a further update of its pharmacology and therapeutic use in the management of organ transplantation. Auckland: ADIS International.
  • Kaplan, B., Burckart, G. J., and Lakkis, F. G. (2012). Immunotherapy in transplantation: principles and practice. Chichester, West Sussex, UK: Wiley Blackwell.
  • Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant Rev (Orlando). 2020 Jan 13:100531.
  • Sanches-Silva A, Testai L, Nabavi SF, Battino M, Pandima Devi K, Tejada S, Sureda A, Xu S, Yousefi B, Majidinia M, Russo GL, Efferth T, Nabavi SM, Farzaei MH. Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway. Pharmacol Res. 2020 Feb;152:104626.
  • Akbari M, Soltani Moghadam R, Elmi R, Nosrati A, Taghiabadi E, Aghdami N. Topical Tacrolimus as an adjunct to Conventional Therapy for Stromal Herpetic Keratitis: a Randomized Clinical Trial. J Ophthalmic Vis Res. 2019 Oct 24;14(4):400-411.
  • Plasmeijer EI, Sachse MM, Gebhardt C, Geusau A, Bouwes Bavinck JN. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC. J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:33-37.

  Related Products https://moleculardepot.com/product/biotinylated-tacrolimus-bsa-conjugate/ https://moleculardepot.com/product/tacrolimus-biotin-conjugate-biotinylated-tacrolimus/ https://moleculardepot.com/product/tacrolimus-biotin-conjugate-peg11-spacer/ https://moleculardepot.com/product/sirolimus-bsa-conjugate/ https://moleculardepot.com/product/everolimus-bsa-conjugate/  

• Short Description:

  Catalog #: P2010001 (1 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5